Market by Product, Application, End-user, and Country | Forecast 2021-2028
The Asia-Pacific pharmaceutical continuous manufacturing market is probable to exhibit growth at 11.11% of CAGR during the considered phase 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed in this
market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of APAC
In India, the pharmaceutical
industry has grown significantly over the years, holding an important position
in the global market. Moreover, the presence of professional scientists and
engineers is likely to boost the industry across the country. According to the
Indian Pharmaceutical Industry Report 2020, India is among the largest generic
drug provider worldwide. However, it is estimated that the country’s pharma
activities are required to shift from batch to continuous manufacturing to
remain relevant in the competitive export situation. This has resulted in the
pharmaceutical sector gearing up for the adoption of continuous manufacturing,
which is further predicted to boost the pharmaceutical continuous manufacturing
market over the considered period.
On the other hand, the surging
aging population has resulted in a rise in the Japanese government’s healthcare
expenditure. Moreover, the population over the age of 65 is likely to grow in
the near future. Here, the government has implemented cost-effective measures,
including promoting generic medicines and biennial drug cost adjustments.
Several pharmaceutical companies are collaborating to cater to the high demand
for generic drugs, further opting for continuous manufacturing. Therefore,
these factors are estimated to drive the progress of the pharmaceutical
continuous manufacturing market across Japan.
Hosokawa Micron Corporation is
engaged in offering process solutions in powder & particle processing
technology, blown film technology, and more. The company has its test centers
for powder and particle processing technology, along with confectionery
technology. Its product portfolio includes Modulomix, which is a continuous
modular paddle mixer designed primarily for the pharmaceutical industry. It has
its research facilities, engineering, and manufacturing services across the
Asia-Pacific region, with its headquarter located in Osaka, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES MODEL
2.1.1. THREAT
OF NEW ENTRANTS
2.1.2. THREAT
OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING
POWER OF BUYERS
2.1.4. BARGAINING
POWER OF SUPPLIERS
2.1.5. COMPETITIVE
RIVALRY
2.2. IMPACT
OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET
2.3. LEGAL,
POLICY, & REGULATORY FRAMEWORK
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
INSIGHTS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS
MANUFACTURING
2.7.2. SURGING
ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS
2.7.3. RISING
HEALTHCARE EXPENDITURE
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES
2.8.2. RISING
CUSTOMER EXPECTATIONS FOR BETTER MEDICINES
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES
2.9.2. SURGE
IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS
3. ASIA-PACIFIC
PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT
3.1. INTEGRATED
CONTINUOUS SYSTEM
3.2. SEMI-CONTINUOUS
SYSTEM
3.3. CONTROL
& SOFTWARE
4. ASIA-PACIFIC
PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION
4.1. FINAL
DRUG PRODUCT MANUFACTURING
4.2. API
MANUFACTURING
5. ASIA-PACIFIC
PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER
5.1. PHARMACEUTICAL
COMPANIES
5.2. CONTRACT
MANUFACTURING ORGANIZATIONS
5.3. OTHER
END-USERS
6. PHARMACEUTICAL
CONTINUOUS MANUFACTURING MARKET - ASIA-PACIFIC
6.1. COUNTRY
ANALYSIS
6.1.1. CHINA
6.1.2. INDIA
6.1.3. JAPAN
6.1.4. AUSTRALIA
& NEW ZEALAND
6.1.5. SOUTH
KOREA
6.1.6. ASEAN
COUNTRIES
6.1.7. REST
OF ASIA-PACIFIC
7. COMPANY
PROFILE
7.1. HOSOKAWA
MICRON CORPORATION
7.2. GEA
GROUP AG
7.3. LB
BOHLE MASCHINEN + VERFAHREN GMBH
7.4. THERMOFISHER
SCIENTIFIC INC
7.5. SIEMENS
HEALTHINEERS
7.6. ELI
LILLY & COMPANY
7.7. PFIZER
INC
7.8. GLATT
GMBH
7.9. SYNTEGON
(FORMERLY BOSCH PACKAGING TECHNOLOGY)
7.10. GEBRUDER
LODIGE MASCHINENBAU GMBH
7.11. KORSCH
AG
7.12. COPERION
GMBH
7.13. MUNSON
MACHINERY COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 3: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $
MILLION)
FIGURE 6: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $
MILLION)
FIGURE 9: ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 10: CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 11: INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 12: JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 13: AUSTRALIA & NEW ZEALAND PHARMACEUTICAL
CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 14: SOUTH KOREA PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 15: ASEAN COUNTRIES PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)
FIGURE 16: REST OF ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS
MANUFACTURING MARKET 2021-2028 (IN $ MILLION)